|
시장보고서
상품코드
1566909
정맥내 수분 보급 요법 시장 : 서비스별, 컴포넌트별, 최종사용자별 : 세계 기회 분석과 산업 예측(2024-2033년)Intravenous Hydration Therapy Market By Service, By Component By End user : Global Opportunity Analysis and Industry Forecast, 2024-2033 |
||||||
정맥내(IV) 수분 보급 요법 시장
정맥내(IV) 수분 보급 요법 시장은 2023년에 23억 달러로 평가되며, 2024-2033년 CAGR 7.8%로 성장하며, 2033년에는 49억 달러에 달할 것으로 예측됩니다.
정맥내(IV) 수분 보급 요법은 약물, 수분, 비타민, 전해질을 정맥을 통해 혈류에 직접 주입하는 의료 시술입니다. 이 치료법은 탈수로 인해 손실된 필수 수분과 영양분을 효율적이고 신속하게 보충할 수 있으며, 매우 효과적인 치료법입니다. 탈수증은 질병, 과도한 음주, 치열한 운동 등으로 인해 체내 수분이 과도하게 손실되는 것을 말합니다. 이 치료는 만성질환 관리, 수술 전후 관리, 중증 감염 및 위장 장애 환자 치료 등 다양한 의료 분야에 적용되고 있습니다.
정맥(IV) 수액 요법 시장의 주요 촉진요인 중 하나는 스트레스 수준이 높은 사람들 사이에서 긴장된 생활 방식이 증가하고 있다는 것입니다. 스트레스가 많은 생활 방식은 개인의 탈수증을 증가시키는 가장 흔한 이유 중 하나입니다. 또한 질병과 입원에 취약한 노년층 인구가 전 세계에서 급증하고 있습니다. 이는 정맥내 수분 보급 요법에 대한 수요를 증가시켜 시장 성장을 가속하고 있습니다. 최근에는 자기 관리와 회춘의 일환으로 정맥내 수분 보급 요법을 시행하는 것이 특히 유명 인사들 사이에서 유행하고 있습니다. 또한 휴식과 휴식의 일환으로 치료를 받을 수 있는 '수분 공급 바'라는 전문센터도 설립되고 있습니다.
그러나 경구용 수액과 같은 다른 수분 보충 요법을 사용할 수 있다는 점이 시장 개척을 억제하고 있습니다. 또한 특히 지방에서는 전용 의료 시설과 잘 훈련된 의료진이 부족하여 시장 확대에 걸림돌이 되고 있습니다. 반면, 기술 발전과 치료 중 투여되는 기존 제제의 개선은 시장 성장에 유리한 기회를 제공합니다. 예를 들어 개인별 맞춤형 솔루션이 개발되어 건강 목표를 달성하는 데 도움을 주고 있습니다.
부문별 리뷰
정맥내 수분 보급 요법 시장은 서비스, 컴포넌트, 최종사용자, 지역으로 분류됩니다. 서비스별로 시장은 면역 부스터, 에너지 부스터, 스킨케어, 편두통, 기타로 나뉩니다. 성분에 따라서는 약용과 비약용으로 나뉩니다. 최종사용자에 따라 병원 및 클리닉, 웰니스 센터 및 스파, 홈헬스케어, 기타로 분류됩니다. 지역별로는 북미, 유럽, 아시아태평양, LAMEA로 분석됩니다.
주요 조사 결과
서비스별로는 면역 증강제가 시장을 독점하고 있습니다.
성분별로는 약용 부문이 시장에서 큰 수요를 획득하고 있습니다.
최종사용자별로는 병원·진료소가 높은 점유율을 획득하고 있습니다.
지역별로는 북미가 시장을 선도하고 있습니다.
본 리포트 커스터마이즈가 가능합니다(별 도비용과 스케줄이 필요합니다.)
- 규제 가이드라인
- 클라이언트의 관심에 부응한 기업 개요 추가
- 기업 개요의 확장 리스트
- 과거 시장 데이터
- 상환 시나리오
목차
제1장 서론
제2장 개요
제3장 시장 구도
- 시장의 정의와 범위
- 주요 조사 결과
- 주요 투자 기회
- 주요 성공 전략
- Porter's Five Forces 분석
- 시장 역학
- 촉진요인
- 억제요인
- 기회
제4장 정맥내 수분 보급 요법 시장 : 서비스별
- 시장 개요
- 면역 부스터
- 에너지·부스터
- 스킨케어
- 편두통
- 기타
제5장 정맥내 수분 보급 요법 시장 : 컴포넌트별
- 시장 개요
- 약용
- 비약용
제6장 정맥내 수분 보급 요법 시장 : 최종사용자별
- 시장 개요
- 병원 클리닉
- 웰니스 센터·스파
- 재택 헬스케어
- 기타
제7장 정맥내 수분 보급 요법 시장 : 지역별
- 시장 개요
- 북미
- 주요 시장 동향과 기회
- 미국의 정맥내(IV) 수분 보급 요법 시장
- 캐나다의 정맥내 수분 보급 요법 시장
- 멕시코의 정맥내 수분 보급 요법 시장
- 유럽
- 주요 시장 동향과 기회
- 프랑스의 정맥내 수분 보급 요법 시장
- 독일의 정맥내 수분 보급 요법 시장
- 이탈리아의 정맥내 수분 보급 요법 시장
- 스페인의 정맥내 수분 보급 요법 시장
- 영국의 정맥내 수분 보급 요법 시장
- 기타 유럽의 정맥내 수분 보급 요법 시장
- 아시아태평양
- 주요 시장 동향과 기회
- 중국의 정맥내 수분 보급 요법 시장
- 일본의 정맥내 수분 보급 요법 시장
- 인도 정맥내 수분 보급 요법 시장
- 한국의 정맥내 수분 보급 요법 시장
- 호주 정맥내 수분 보급 요법 시장
- 기타 아시아태평양의 정맥내 수분 보급 요법 시장
- 라틴아메리카·중동 및 아프리카
- 주요 시장 동향과 기회
- 브라질의 정맥내 수분 보급 요법 시장
- 남아프리카공화국 정맥내 수분 보급 요법 시장
- 사우디아라비아의 정맥내 수분 보급 요법 시장
- 기타 라틴아메리카·중동 및 아프리카의 정맥내 수분 보급 요법 시장
제8장 경쟁 구도
- 서론
- 주요 성공 전략
- 주요 10 기업의 제품 지도제작
- 경쟁 대시보드
- 경쟁 히트맵
- 주요 기업의 포지셔닝(2023년)
제9장 기업 개요
- Davita
- Nikkiso Co. Ltd.
- Core IV Therapy, LLC
- Cryojuvenate UK Ltd.
- B. Braun Medical Inc.
- Otsuka Pharmaceutical Co., Ltd.
- NexGen Health
- JW Life Science Corporation
- Amanta Healthcare Limited.
- Baxter International Inc.
Intravenous (IV) Hydration Therapy Market
The intravenous (IV) hydration therapy market was valued at $2.3 billion in 2023 and is projected to reach $4.9 billion by 2033, growing at a CAGR of 7.8% from 2024 to 2033.
Intravenous (IV) hydration therapy is the medical procedure in which medications, fluids, vitamins, and electrolytes are infused directly into the bloodstream through a vein. The therapy is a highly effective procedure as it ensures efficient and quick replenishment of essential fluids and nutrients lost due to dehydration. Dehydration is the excessive loss of fluids from the body caused by some illness, excessive alcohol consumption, or intense physical activity. The treatment is applicable in diverse medical settings for the management of chronic conditions, preoperative & postoperative care, and to cure patients with severe infections or gastrointestinal problems.
One of the key drivers of the intravenous (IV) hydration therapy market is increase in uptight lifestyle among individuals with high stress levels. A stressed lifestyle is one of the most common reasons for rising dehydration among individuals. In addition, the geriatric population is growing exponentially across the globe, who are highly susceptible to ailments and hospitalization. This boosts the demand for IV hydration therapy, thus augmenting the market growth. In recent times, the administration of IV therapy as a part of self-care routine or rejuvenation is trending, particularly among celebrities. Moreover, specialized centers called "hydration bars" are being established for people to receive therapy as a form of relaxation.
However, the availability of other alternatives for hydration therapy, such as the oral rehydration solutions restrain the development of the market. Furthermore, the shortage of dedicated medical facilities and well-trained staff, particularly in rural areas, presents challenges for the expansion of the market. On the contrary, advancements in technology and modifications in the conventional formulations administered during treatment are presenting lucrative opportunities for market growth. For instance, personalized solutions are being developed according to the requirements of every individual, hence aiding them to achieve their health goal.
Segment Review
The intravenous (IV) hydration therapy market is segmented into service, component, end user, and region. On the basis of service, the market is divided into immune boosters, energy boosters, skin care, migraine, and others. By component, it is bifurcated into medicated and non-medicated. As per end user, it is categorized into hospital & clinics, wellness centers & spas, home healthcare, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of service, the immune boosters segment dominates the market.
By component, the medicated segmented experiences significant demand in the market.
As per end user, the hospital & clinics segment acquires a high share of the market.
Region wise, North America leads the market.
Competition Analysis
The major players operating in the global intravenous (IV) hydration therapy market include Davita, Nikkiso Co. Ltd., Core IV Therapy, LLC, Cryojuvenate UK Ltd., B. Braun Medical Inc., Otsuka Pharmaceutical Co., Ltd., NexGen Health, JW Life Science Corporation, Amanta Healthcare Limited., and Baxter International Inc. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Expanded list for Company Profiles
- Historic market data
- Reimbursement Scenario
Key Market Segments
By Service
- Immune boosters
- Energy boosters
- Skin care
- Migraine
- Others
By Component
- Medicated
- Non-medicated
By End User
- Hospital clinics
- Wellness centers spas
- Home healthcare
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
Key Market Players:
- Davita
- Nikkiso Co. Ltd.
- Core IV Therapy, LLC
- Cryojuvenate UK Ltd.
- B. Braun Medical Inc.
- Otsuka Pharmaceutical Co., Ltd.
- NexGen Health
- JW Life Science Corporation
- Amanta Healthcare Limited.
- Baxter International Inc.?
TABLE OF CONTENTS
CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.5. Market Dynamics
- 3.5.1. Drivers
- 3.5.2. Restraints
- 3.5.3. Opportunities
CHAPTER 4: INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY SERVICE
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Service
- 4.2. Immune Boosters
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Energy Boosters
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- 4.4. Skin Care
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
- 4.5. Migraine
- 4.5.1. Key Market Trends, Growth Factors and Opportunities
- 4.5.2. Market Size and Forecast, By Region
- 4.5.3. Market Share Analysis, By Country
- 4.6. Others
- 4.6.1. Key Market Trends, Growth Factors and Opportunities
- 4.6.2. Market Size and Forecast, By Region
- 4.6.3. Market Share Analysis, By Country
CHAPTER 5: INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY COMPONENT
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Component
- 5.2. Medicated
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Non-medicated
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
CHAPTER 6: INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY END USER
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By End User
- 6.2. Hospital Clinics
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Wellness Centers Spas
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4. Home Healthcare
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
- 6.5. Others
- 6.5.1. Key Market Trends, Growth Factors and Opportunities
- 6.5.2. Market Size and Forecast, By Region
- 6.5.3. Market Share Analysis, By Country
CHAPTER 7: INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY REGION
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
- 7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Service
- 7.2.3. Market Size and Forecast, By Component
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Intravenous (IV) Hydration Therapy Market
- 7.2.6.1. Market Size and Forecast, By Service
- 7.2.6.2. Market Size and Forecast, By Component
- 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada Intravenous (IV) Hydration Therapy Market
- 7.2.7.1. Market Size and Forecast, By Service
- 7.2.7.2. Market Size and Forecast, By Component
- 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico Intravenous (IV) Hydration Therapy Market
- 7.2.8.1. Market Size and Forecast, By Service
- 7.2.8.2. Market Size and Forecast, By Component
- 7.2.8.3. Market Size and Forecast, By End User
- 7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Service
- 7.3.3. Market Size and Forecast, By Component
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. France Intravenous (IV) Hydration Therapy Market
- 7.3.6.1. Market Size and Forecast, By Service
- 7.3.6.2. Market Size and Forecast, By Component
- 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. Germany Intravenous (IV) Hydration Therapy Market
- 7.3.7.1. Market Size and Forecast, By Service
- 7.3.7.2. Market Size and Forecast, By Component
- 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. Italy Intravenous (IV) Hydration Therapy Market
- 7.3.8.1. Market Size and Forecast, By Service
- 7.3.8.2. Market Size and Forecast, By Component
- 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Spain Intravenous (IV) Hydration Therapy Market
- 7.3.9.1. Market Size and Forecast, By Service
- 7.3.9.2. Market Size and Forecast, By Component
- 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. UK Intravenous (IV) Hydration Therapy Market
- 7.3.10.1. Market Size and Forecast, By Service
- 7.3.10.2. Market Size and Forecast, By Component
- 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest of Europe Intravenous (IV) Hydration Therapy Market
- 7.3.11.1. Market Size and Forecast, By Service
- 7.3.11.2. Market Size and Forecast, By Component
- 7.3.11.3. Market Size and Forecast, By End User
- 7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Service
- 7.4.3. Market Size and Forecast, By Component
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. China Intravenous (IV) Hydration Therapy Market
- 7.4.6.1. Market Size and Forecast, By Service
- 7.4.6.2. Market Size and Forecast, By Component
- 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. Japan Intravenous (IV) Hydration Therapy Market
- 7.4.7.1. Market Size and Forecast, By Service
- 7.4.7.2. Market Size and Forecast, By Component
- 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. India Intravenous (IV) Hydration Therapy Market
- 7.4.8.1. Market Size and Forecast, By Service
- 7.4.8.2. Market Size and Forecast, By Component
- 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. South Korea Intravenous (IV) Hydration Therapy Market
- 7.4.9.1. Market Size and Forecast, By Service
- 7.4.9.2. Market Size and Forecast, By Component
- 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. Australia Intravenous (IV) Hydration Therapy Market
- 7.4.10.1. Market Size and Forecast, By Service
- 7.4.10.2. Market Size and Forecast, By Component
- 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia-Pacific Intravenous (IV) Hydration Therapy Market
- 7.4.11.1. Market Size and Forecast, By Service
- 7.4.11.2. Market Size and Forecast, By Component
- 7.4.11.3. Market Size and Forecast, By End User
- 7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Service
- 7.5.3. Market Size and Forecast, By Component
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Intravenous (IV) Hydration Therapy Market
- 7.5.6.1. Market Size and Forecast, By Service
- 7.5.6.2. Market Size and Forecast, By Component
- 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. South Africa Intravenous (IV) Hydration Therapy Market
- 7.5.7.1. Market Size and Forecast, By Service
- 7.5.7.2. Market Size and Forecast, By Component
- 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. Saudi Arabia Intravenous (IV) Hydration Therapy Market
- 7.5.8.1. Market Size and Forecast, By Service
- 7.5.8.2. Market Size and Forecast, By Component
- 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. Rest of LAMEA Intravenous (IV) Hydration Therapy Market
- 7.5.9.1. Market Size and Forecast, By Service
- 7.5.9.2. Market Size and Forecast, By Component
- 7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top Winning Strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
- 9.1. Davita
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
- 9.2. Nikkiso Co. Ltd.
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
- 9.3. Core IV Therapy, LLC
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
- 9.4. Cryojuvenate UK Ltd.
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
- 9.5. B. Braun Medical Inc.
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
- 9.6. Otsuka Pharmaceutical Co., Ltd.
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
- 9.7. NexGen Health
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
- 9.8. JW Life Science Corporation
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
- 9.9. Amanta Healthcare Limited.
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
- 9.10. Baxter International Inc.?
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments
